BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 21994653)

  • 1. Recent advances in hepatitis C virus cell entry.
    Bartosch B; Dubuisson J
    Viruses; 2010 Mar; 2(3):692-709. PubMed ID: 21994653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors.
    Burlone ME; Budkowska A
    J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cell infection with hepatitis C virus (HCV)--a new paradigm in virus-cell interaction.
    Budkowska A
    Pol J Microbiol; 2009; 58(2):93-8. PubMed ID: 19824391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of HCV entry into host cells.
    Douam F; Lavillette D; Cosset FL
    Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection and tight junction proteins: The ties that bind.
    Mailly L; Baumert TF
    Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus entry into the hepatocyte.
    Belouzard S; Cocquerel L; Dubuisson J
    Cent Eur J Biol; 2011; 6(6):933-945. PubMed ID: 32215118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin association with CD81 defines hepatitis C virus entry.
    Harris HJ; Davis C; Mullins JG; Hu K; Goodall M; Farquhar MJ; Mee CJ; McCaffrey K; Young S; Drummer H; Balfe P; McKeating JA
    J Biol Chem; 2010 Jul; 285(27):21092-102. PubMed ID: 20375010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SR-BI partner PDZK1 facilitates hepatitis C virus entry.
    Eyre NS; Drummer HE; Beard MR
    PLoS Pathog; 2010 Oct; 6(10):e1001130. PubMed ID: 20949066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
    Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
    J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
    Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
    PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
    Zhu YZ; Qian XJ; Zhao P; Qi ZT
    World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
    Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
    J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection of neuroepithelioma cell lines.
    Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
    Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay among cellular polarization, lipoprotein metabolism and hepatitis C virus entry.
    Benedicto I; Molina-Jiménez F; Moreno-Otero R; López-Cabrera M; Majano PL
    World J Gastroenterol; 2011 Jun; 17(22):2683-90. PubMed ID: 21734774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of lipoprotein receptors in the entry of hepatitis C virus.
    Lyu J; Imachi H; Fukunaga K; Yoshimoto T; Zhang H; Murao K
    World J Hepatol; 2015 Oct; 7(24):2535-42. PubMed ID: 26527170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
    Sourisseau M; Michta ML; Zony C; Israelow B; Hopcraft SE; Narbus CM; Parra Martín A; Evans MJ
    PLoS Pathog; 2013 Mar; 9(3):e1003244. PubMed ID: 23555257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.